Sirirat Tubsungnoen Rattanachan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sirirat Tubsungnoen Rattanachan has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Paritat Thaitalay
School of Ceramic Engineering, Institute of Engineering, Suranaree University of Technology
10 shared publicationsSawitri Srisuwan
School of Ceramic Engineering, Institute of Engineering, Suranaree University of Technology
10 shared publicationsOranich Thongsri
School of Ceramic Engineering, Institute of Engineering, Suranaree University of Technology
8 shared publicationsRawee Dangwiriyakul
School of Ceramic Engineering, Institute of Engineering, Suranaree University of Technology
5 shared publicationsSanong Suksaweang
School of Pathology and Laboratory Medicine, Institute of Medicine, Suranaree University of Technology, Nakhon Ratchasima, Thailand
5 shared publicationsChutima Talabnin
School of Biochemistry, Institute of Science, Suranaree University of Technology, Nakhon Ratchasima, Thailand
4 shared publications
Latest Publications
- 28 March 2025
- Published by Springer Nature
- p. 67-75
Chloride and Sulfate Resistance of the Alternative Raw Materials-Based Geopolymer
- 28 March 2025
- Published by Springer Nature
- p. 67-75
Chloride and Sulfate Resistance of the Alternative Raw Materials-Based Geopolymer
- 13 June 2024
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 10 (4) , 045043
Feasibility biomechanical study of injectable Biphasic Calcium Phosphate bone cement augmentation of the proximal femoral nail antirotation (PFNA) for the treatment of two intertrochanteric fractures using cadaveric femur
This study evaluated the feasibility of the femoral bone after fixation using biphasic calcium phosphate cement-augmentation of the proximal femoral nail antirotation (PFNA) compared with PFNA without cement. This study presented to compare the stiffness, fatigue testing, and compressive strength between stable (AO31-A2.1) and unstable (AO31-A3.3) intertrochanteric fractures treated by cement augmented PFNA of the cadaveric femoral. Biphasic calcium phosphate cement was injected to align and compatible with PFNA and the reconstructive procedure was monitored the cement placement using x-ray imaging during operation. The testing demonstrated that the cement could be injected through a small needle (13 G, 16 cm length, 1.8 mm inner diameter) within a suitable operating time. The feasibility study of the biomechanical testing was divided into three tests: stiffness test, fatigue cyclic load, and compression test. The results showed that the cement-augmented specimens exhibited higher stiffness than the control specimens without cement. The cement-augmented specimens also showed lower strain energy during the fatigue test, resulting in higher compressive strength (4730.7 N) compared to the control specimens (3857.4 N). There is a correlation between BMD and fracture load and the increase in compression load of the cement-augmented femoral compared to the controls as well as an increase in strain energy of fatigue cyclic testing was found. Biphasic calcium phosphate cement-augmented of the PFNA biomechanically enhanced the cut-out resistance in intertrochanteric fracture. This procedure is especially efficient for unstable intertrochanteric fracture suggesting the potential benefits of using biphasic calcium phosphate cement in medical applications.
- 13 June 2024
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 10 (4) , 045043
Feasibility biomechanical study of injectable Biphasic Calcium Phosphate bone cement augmentation of the proximal femoral nail antirotation (PFNA) for the treatment of two intertrochanteric fractures using cadaveric femur
This study evaluated the feasibility of the femoral bone after fixation using biphasic calcium phosphate cement-augmentation of the proximal femoral nail antirotation (PFNA) compared with PFNA without cement. This study presented to compare the stiffness, fatigue testing, and compressive strength between stable (AO31-A2.1) and unstable (AO31-A3.3) intertrochanteric fractures treated by cement augmented PFNA of the cadaveric femoral. Biphasic calcium phosphate cement was injected to align and compatible with PFNA and the reconstructive procedure was monitored the cement placement using x-ray imaging during operation. The testing demonstrated that the cement could be injected through a small needle (13 G, 16 cm length, 1.8 mm inner diameter) within a suitable operating time. The feasibility study of the biomechanical testing was divided into three tests: stiffness test, fatigue cyclic load, and compression test. The results showed that the cement-augmented specimens exhibited higher stiffness than the control specimens without cement. The cement-augmented specimens also showed lower strain energy during the fatigue test, resulting in higher compressive strength (4730.7 N) compared to the control specimens (3857.4 N). There is a correlation between BMD and fracture load and the increase in compression load of the cement-augmented femoral compared to the controls as well as an increase in strain energy of fatigue cyclic testing was found. Biphasic calcium phosphate cement-augmented of the PFNA biomechanically enhanced the cut-out resistance in intertrochanteric fracture. This procedure is especially efficient for unstable intertrochanteric fracture suggesting the potential benefits of using biphasic calcium phosphate cement in medical applications.
- 23 February 2024
- Published by Elsevier in Dental Materials
- Vol. 40 (4) , 716-727
Enhanced remineralisation ability and antibacterial properties of sol-gel glass ionomer cement modified by fluoride containing strontium-based bioactive glass or strontium-containing fluorapatite
- 23 February 2024
- Published by Elsevier in Dental Materials
- Vol. 40 (4) , 716-727
Enhanced remineralisation ability and antibacterial properties of sol-gel glass ionomer cement modified by fluoride containing strontium-based bioactive glass or strontium-containing fluorapatite
- 10 November 2023
- Published by Suranaree University of Technology in Suranaree Journal of Science and Technology
- Vol. 30 (5) , 030147(1-9)
Resistance of Chloride and Sulfate of Geopolymer based on fly ash and silica fume as alternative raw materials.
Web site created using create-react-app
- 10 November 2023
- Published by Suranaree University of Technology in Suranaree Journal of Science and Technology
- Vol. 30 (5) , 030147(1-9)
Resistance of Chloride and Sulfate of Geopolymer based on fly ash and silica fume as alternative raw materials.
Web site created using create-react-app
- 3 April 2023
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 111 (9) , 1406-1422
Primary human osteoblast and mesenchymal stem cell responses to apatite/tricalcium phosphate bone cement modified with polyacrylic acid and bioactive glass
In this work, three different modified cements, control apatite/beta‐tricalcium phosphate cement (CPC), polymeric CPC (p‐CPC), and bioactive glass added polymeric cement (p‐CPC/BG) were evaluated regarding their physical properties and the responses of primary human osteoblast cells (HObs) and mesenchymal stem cells (MSCs). Although polyacrylic acid (PAA) increased compressive strength and Young's modulus of the cement, it could cause poor apatite phase formation, a prolonged setting time, and a lower degradation rate. Consequently, bioactive glass (BG) was added to PAA/cement to improve its physical properties, such as compressive strength, Young's modulus, setting time, and degradation. For in vitro testing, HObs viability was assessed under two culture systems with cement‐preconditioned medium (indirect) and with cement (direct). HObs viability was examined in direct contact with cements treated by different prewashing conditions. HObs presented a more well spread morphology on cement soaked in medium overnight, as compared to other cements with no treatment and washing in PBS. In addition, the proliferation, differentiation, and total collagen production of both HObs and MSCs adhered to the cement were detected. Cells showed excellent proliferation on PAA/cement and PAA/BG/cement. Furthermore, the higher released Si ion and lower acidosis of PAA/BG/cement‐conditioned medium resulted in an increase in osteogenic differentiation (HObs and MSCs) and enhanced collagen production (HObs in osteogenic medium and MSCs in control medium). Therefore, our findings suggest that BG incorporated PAA/apatite/β‐TCP cement could be a promising formula for bone repair applications.
- 3 April 2023
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 111 (9) , 1406-1422
Primary human osteoblast and mesenchymal stem cell responses to apatite/tricalcium phosphate bone cement modified with polyacrylic acid and bioactive glass
In this work, three different modified cements, control apatite/beta‐tricalcium phosphate cement (CPC), polymeric CPC (p‐CPC), and bioactive glass added polymeric cement (p‐CPC/BG) were evaluated regarding their physical properties and the responses of primary human osteoblast cells (HObs) and mesenchymal stem cells (MSCs). Although polyacrylic acid (PAA) increased compressive strength and Young's modulus of the cement, it could cause poor apatite phase formation, a prolonged setting time, and a lower degradation rate. Consequently, bioactive glass (BG) was added to PAA/cement to improve its physical properties, such as compressive strength, Young's modulus, setting time, and degradation. For in vitro testing, HObs viability was assessed under two culture systems with cement‐preconditioned medium (indirect) and with cement (direct). HObs viability was examined in direct contact with cements treated by different prewashing conditions. HObs presented a more well spread morphology on cement soaked in medium overnight, as compared to other cements with no treatment and washing in PBS. In addition, the proliferation, differentiation, and total collagen production of both HObs and MSCs adhered to the cement were detected. Cells showed excellent proliferation on PAA/cement and PAA/BG/cement. Furthermore, the higher released Si ion and lower acidosis of PAA/BG/cement‐conditioned medium resulted in an increase in osteogenic differentiation (HObs and MSCs) and enhanced collagen production (HObs in osteogenic medium and MSCs in control medium). Therefore, our findings suggest that BG incorporated PAA/apatite/β‐TCP cement could be a promising formula for bone repair applications.
- 3 January 2022
- Published by Springer Nature in Journal of Materials Science
- Vol. 57 (1) , 633-650
Structural evaluation of ZnO substitution for CaO in glass ionomer cement synthesized by sol-gel method and their properties
- 3 January 2022
- Published by Springer Nature in Journal of Materials Science
- Vol. 57 (1) , 633-650
Structural evaluation of ZnO substitution for CaO in glass ionomer cement synthesized by sol-gel method and their properties
- 31 March 2021
- Published by Springer Nature in Journal of Sol-Gel Science and Technology
- Vol. 98 (3) , 441-451
Influence of Al2O3 and P2O5 contents in sol-gel ionomer glass system on the structure and their cement properties
- 31 March 2021
- Published by Springer Nature in Journal of Sol-Gel Science and Technology
- Vol. 98 (3) , 441-451
Influence of Al2O3 and P2O5 contents in sol-gel ionomer glass system on the structure and their cement properties
- 26 March 2021
- Published by Wiley in International Journal of Applied Ceramic Technology
- Vol. 18 (4) , 1365-1378
Influence of polyacrylic acid (PAA)/Na 2 HPO 4 mixture on biphasic calcium phosphate cement: Enhancing strength and cell viability
This study has investigated the effect of combination of new liquid phase mixture of disodium hydrogen phosphate (Na 2 HPO 4 ) and polyacrylic acid (PAA) on the compressive strength, setting time, bioactivity, and cytotoxicity of biphasic calcium phosphate cement. The PAA was known as one of water‐soluble and biocompatible polymers to improve the mechanical performances of the bone cement, but it usually inhibits the phase conversion to hydroxyapatite after the cement has already set. The aim of this work was to evaluate the incorporation of the mixture of PAA and Na 2 HPO 4 into biphasic cement. We have found the crucial concentration for adding PAA/Na 2 HPO 4 at 30:70 v/v% to enhance the mechanical strength, cell viability, and maintain bioactivity. The phase composition and crosslinking reaction between PAA and alpha‐tricalcium phosphate (α‐TCP) powder were detected by XRD and FTIR techniques. The beta‐tricalcium phosphate (β‐TCP) was added in the formula to achieve the biphasic cement, which composed of β‐TCP and apatite/calcium deficient‐hydroxyapatite (CD‐HA) in the final product. The biphasic granule commercial product was used as comparison in the cell viability test. This work had been confirmed that the cement was a nontoxic material. Therefore, our results suggest that the PAA/Na 2 HPO 4 could be beneficial for further clinical applications.
- 26 March 2021
- Published by Wiley in International Journal of Applied Ceramic Technology
- Vol. 18 (4) , 1365-1378
Influence of polyacrylic acid (PAA)/Na 2 HPO 4 mixture on biphasic calcium phosphate cement: Enhancing strength and cell viability
This study has investigated the effect of combination of new liquid phase mixture of disodium hydrogen phosphate (Na 2 HPO 4 ) and polyacrylic acid (PAA) on the compressive strength, setting time, bioactivity, and cytotoxicity of biphasic calcium phosphate cement. The PAA was known as one of water‐soluble and biocompatible polymers to improve the mechanical performances of the bone cement, but it usually inhibits the phase conversion to hydroxyapatite after the cement has already set. The aim of this work was to evaluate the incorporation of the mixture of PAA and Na 2 HPO 4 into biphasic cement. We have found the crucial concentration for adding PAA/Na 2 HPO 4 at 30:70 v/v% to enhance the mechanical strength, cell viability, and maintain bioactivity. The phase composition and crosslinking reaction between PAA and alpha‐tricalcium phosphate (α‐TCP) powder were detected by XRD and FTIR techniques. The beta‐tricalcium phosphate (β‐TCP) was added in the formula to achieve the biphasic cement, which composed of β‐TCP and apatite/calcium deficient‐hydroxyapatite (CD‐HA) in the final product. The biphasic granule commercial product was used as comparison in the cell viability test. This work had been confirmed that the cement was a nontoxic material. Therefore, our results suggest that the PAA/Na 2 HPO 4 could be beneficial for further clinical applications.
- 28 August 2020
- Published by IOP Publishing in Biomedical Materials
- Vol. 15 (5) , 055038
Development of injectable chitosan/biphasic calcium phosphate bone cement and in vitro and in vivo evaluation
Injectable biphasic calcium phosphate bone cements (BCPCs) composed of β-tricalcium phosphate (β-TCP) and hydroxyapatite (HA) have been intensively investigated because of their high rate of biodegradation, bioactivity and osteoconductivity, which can be adjusted by changing the ratio between β-TCP and HA phases after setting. The aim of this study was to evaluate the performance of 1 wt% chitosan fiber additive with biphasic calcium phosphate as an injectable bone cement both in vitro and in vivo . In vitro evaluation of compressive strength, degradation rate, morphology, and cell and alkaline phosphatase activities was done by comparison with bone cement without β-TCP. The in vivo results for micro-CT scanning and histological examinations for three groups (control, BCPC and commercial biphasic calcium phosphate granules) were characterized and compared. After the addition of 20 wt% β-TCP to calcium phosphate cement, the initial and final setting times of the sample were 3.92 min and 11.46 min, respectively, which were not significantly different from cement without β-TCP. The degradation time of the BCPC material was longer than that of calcium phosphate cement alone. The healing process was significantly faster for BCPC than for the control and commercial product groups. Therefore, this is the first evidence that BCPC is an attractive option for bone surgery due to its faster stimulation of healing and faster degradation rate.
- 28 August 2020
- Published by IOP Publishing in Biomedical Materials
- Vol. 15 (5) , 055038
Development of injectable chitosan/biphasic calcium phosphate bone cement and in vitro and in vivo evaluation
Injectable biphasic calcium phosphate bone cements (BCPCs) composed of β-tricalcium phosphate (β-TCP) and hydroxyapatite (HA) have been intensively investigated because of their high rate of biodegradation, bioactivity and osteoconductivity, which can be adjusted by changing the ratio between β-TCP and HA phases after setting. The aim of this study was to evaluate the performance of 1 wt% chitosan fiber additive with biphasic calcium phosphate as an injectable bone cement both in vitro and in vivo . In vitro evaluation of compressive strength, degradation rate, morphology, and cell and alkaline phosphatase activities was done by comparison with bone cement without β-TCP. The in vivo results for micro-CT scanning and histological examinations for three groups (control, BCPC and commercial biphasic calcium phosphate granules) were characterized and compared. After the addition of 20 wt% β-TCP to calcium phosphate cement, the initial and final setting times of the sample were 3.92 min and 11.46 min, respectively, which were not significantly different from cement without β-TCP. The degradation time of the BCPC material was longer than that of calcium phosphate cement alone. The healing process was significantly faster for BCPC than for the control and commercial product groups. Therefore, this is the first evidence that BCPC is an attractive option for bone surgery due to its faster stimulation of healing and faster degradation rate.